2022 Biopharma Industry Outlook: Highlights, Trends & Opportunities
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the biopharma sector. This segment is poised for significant growth, scientific advancement and consolidation.
2022 Biopharma Industry Outlook: Highlights, Trends & Opportunities
Market Insight: Mike Casasanta, PhD, Nick Frame, PhD and Oded Ben-Joseph, PhD
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the biopharma sector. This segment is poised for significant growth, scientific advancement and consolidation.
News
Outcome Capital Announces Partnership of ZIEN Medical and Averra Holdings
Outcome Capital served as exclusive strategic and financial advisor to ZIEN
Read MoreResources
Outcome Capital Life Science Market Pulse, May 2025
Outcome Capital Life Science Market Pulse May 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
